QUOTED. 9 January 2020. Rita Redberg & James Salazar.
University of California San Francisco physicians Rita Redberg and James Salazar share concerns about the state of medtech postmarket surveillance in the US in a recent editorial published by JAMA Internal Medicine. See what they wrote here.
“When there is a device safety signal or recall, it is appalling that the United States … lacks even a rudimentary means to track medical devices.” – Rita Redberg & James Salazar, physicians, University of California San Francisco
Click here for a free trial of Medtech Insight